OMO (Original Manufacturing Operation)

OMO, Short for original manufacturing operation, which is service term for our customers that have their own registered drug and branding in their destination countries.

During OMO operation, we provide our customers the finished products, half-finished products and also bulk materials (if possible). It is very effective for accredit customers who have their products licenses in their own region and have the need that their own brand should be used in process of marketing the products.

Normally, Kelun Bio-Pharam's or kelun's contractual manufacturer's name as the manufacturer should be remained on the statement (packaging and insert) and drug should be registered in the designed region during OMO. Kelun is the original manufacture and has the responsibility to the products, including warranty and etc.

Certain products are not permitted to be reselled in terms of bulk or raw material form, e.g. plasma products and vaccines, please check the policy and standard page for details.

 

 

 


Chinese firm de
Two months ago, China's State Food and Drug Administration (SFDA) issued its approval allowing Shenzhen-based SiBiono Gene Technology Co Ltd to produce its gene therapy medication.

·

India, China to team up to promote health care

·

China's drug watchdog sends supervisors to blood, vaccine pharmaceutical producers
China's drug watchdog has sent supervisors to firms producing blood-based drugs and vaccines across China to crack down on the production of fake drugs.


Copyright & Legal Disclaimer | Privacy Policy                         © Kelun Bio-Pharma